Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Pfizer Sees Future Deals as China Biopharma Consolidates

publication date: Jan 21, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
To increase dealmaking in China, Pfizer has built a Shanghai-based business development team. On the one hand, the mega-pharma is looking forward to revenue growth in the China pharma market, while on the other hand it expects China’s famously fragmented pharmaceutical industry to begin a long-awaiting process of consolidation. For both reasons, China figures large in the company’s development plans for the next three to five years. More details...

Stock Symbol: (NYSE: PFE)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...